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Abstract
Mammalian hepatic carboxylesterases (CEs) play important roles in the detoxification of ester-
containing pyrethroids, which are widely used for the control of agricultural pests and disease vectors
such as mosquitoes. Pyrethroids and pyrethroid-like fluorescent substrates exhibit a consistent pattern
of stereoselective hydrolysis by a recombinant murine hepatic CE. We sought to understand whether
this pattern is maintained in other hepatic CEs and to unravel the origin of the stereoselectivity. We
found that all hepatic CEs tested displayed a consistent pattern of stereoselective hydrolysis: the
chiral center(s) in the acid moiety more strongly influenced stereoselective hydrolysis than the chiral
center in the alcohol moiety. For cypermethrin analogues with a cyclopropane ring in the acid moiety,
trans-isomers were generally hydrolyzed faster than the corresponding cis-isomers. For fenvalerate
analogues without a cyclopropane ring in the acid moiety, 2R-isomers were better substrates than
2S-isomers. These general hydrolytic patterns were examined by modeling the pyrethroid-like
analogues within the active site of the crystal structure of human carboxylesterase 1 (hCE1).
Stereoselective steric clashes were found to occur between the acid moieties and either the catalytic
Ser loop (residues 219-225) or the oxyanion hole (residues140-144). These clashes appeared to
explain the stereopreference between trans- and cis-isomers of cypermethrin analogues, and the
2R- and 2S-isomers of fenvalerate analogues by hCE1. The implications these findings have on the
design and use of effective pesticides are discussed.
Introduction
Carboxylesterases (CEs) play a major role in the metabolism, detoxification, and elimination
of endogenous and exogenous esters (1). Various CEs are present in a wide variety of organs
and tissues of many mammalian species including humans, in which the highest hydrolase
activity occurs in the liver (2). These enzymes are α/β fold hydrolases, and the family shares
a common mechanism of hydrolysis involving a catalytic triad composed of a serine, a
histidine, and either an aspartic acid or a glutamic acid residue (3). These enzymes can
hydrolyze a wide variety of ester, amide, and thioester substrates. Despite their promiscuity,
however, many CEs display stereo-/enantioselective hydrolysis toward certain substrates.
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Currently, pyrethroids are among the most widely used insecticides in the world. The use of
pyrethroids will probably increase as organophosphates are phased out, resulting in an
increased incidence of human exposure. Because of the rapid biodegradation by mammalian
and human liver enzymes (e.g., esterases and monooxygenases), pyrethroids are well-known
to present only low to moderate oral toxicity to mammals (4) and to be generally safe for
humans (5). However, evidence has suggested that significant long-term and high level
exposure to pyrethroids might cause human health problems such as suppressive effects on the
immune system (6), endocrine disruption (7), with lymph node, splenic, and testicular damage
as well as carcinogenesis (8,9). Moreover, the expression of CE isozymes varies with life stage,
individuals, sex, and species (1), resulting in differential susceptibility to the same pyrethroid
between human infants and adults (10) or between neonatal and adult mammals (11).
Stereoisomerism exists in most pyrethroid insecticides, and different stereoisomers of the same
pyrethroid may exhibit remarkable differences in resistance to hydrolysis by the same CE
isozyme (12,13). This hydrolytic stability may contribute to differential toxicity. Thus,
knowledge of the pyrethroid structure-hydrolytic activity relationship and the tissue
distribution of CE isozymes is a critical component to the understanding of the metabolism of
the natural pyrethrines and their analogues (the pyrethroids).
Optically pure pyrethroid-like fluorescent substrates are useful in elucidating the origin of
stereoselective hydrolysis by different CE isozymes in mammals and/or humans. These
substrates have been developed in our laboratory to facilitate such a measurement (13).
Carboxylesterases hydrolyze the ester bond, releasing the cyanohydrin which quickly
rearranges into the corresponding fluorescent aldehyde under neutral or basic conditions (14).
A murine liver CE (NCBI accession no. BAC36707) exhibited similar stereoselective
hydrolysis of pyrethroids (e.g., cypermethrin) and pyrethroid-like fluorescent substrates (14).
It was not clear, however, whether other mammalian and human hepatic CEs would exhibit
this stereoselectivity.
Recently, X-ray crystal structures of human and rabbit liver CEs (hCE1 and rCE) have been
obtained in the Redinbo laboratory (16,17). The origin of the stereoselective hydrolysis of
cocaine by hCE1 has also been examined recently (17). This structure made it possible to study
the molecular basis for stereoselective hydrolysis of these fluorescent substrates and/or
pyrethroids in mammals or humans. Thus, the major objectives of this study were (1) to evaluate
the stereoselectivity of CEs including recombinant and purified hCE1, commercial porcine,
and rabbit liver CEs toward the stereoisomers of these fluorescent substrates (Figure 1), (2) to
combine the data obtained from recombinant and purified murine liver CEs (NCBI accession
nos. BAC36707 and NM_133960 (13)) and compare the differences in stereoselective of
different CEs toward these fluorescent substrates, and (3) to probe the origin of stereoselectivity
of the pyrethroid-like fluorescent substrates using the crystal structures of hCE1.
Materials and Methods
Chemicals. All fluorescent substrates were synthesized as reported previously (13), and the
chemical purity of these substrates determined by GC/MS (13) is over 99.9%. Full spectral
characterization is provided separately (13). Optical purity of eight stereoisomers of
cypermethrin analogues labeled as 1R cis, αR; 1R cis, αS; 1R trans, αR; 1R trans, αS; 1S cis,
αR; 1S cis, αS; 1S trans, αR; and 1S trans, αS (Figure 1,13) is 97.7%, 98.8%, 98.7%, 99.9%,
99.4%, 99.4%, 99.9%, and 98.0%, respectively. Optical purity of four stereoisomers of
fenvalerate analogues labeled as 2R, αR;2R, αS;2S, αR; and 2S, αS (Figure 1,13) is 99.9%,
99.1%, 100%, and 98%, respectively. 6-Methoxy-2-naphthaldehyde (>99% purity) was
obtained from AVOCADO Research Chemical, Ltd. (Heysham, Lancaster U.K.). Porcine liver
CEs (catalog no. E2884) and rabbit liver CEs (catalog no. E-9636) were purchased from Sigma
Chemical Co. (St. Louis, MO). Both porcine and rabbit liver CEs are a mixture of multiple
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isozymes. Two recombinant mouse liver carboxylesterases (NCBI accession no. BAC 36707
and NM_133960) were purified as previously reported (12).
Preparation of hCE1. Recombinant hCE1 was purified from a baculovirus expression system
[Nishi, K., et al. (manuscript in preparation)]. In brief, recombinant baculovirus was generated
by coinfection of a full-length cDNA encoding hCE1 cloned into a pAcUW21 transfer vector
(BD Biosciences Pharmingen, San Diego, CA) with virus DNA into Sf21 insect cells. Then,
recombinant baculovirus-infected High Five insect cells were harvested and homogenized 72
h post-infection, and hCE1 was solubilized by adding 1% (final concentration) octyl-β-D-
glucopyranoside. After ultracentrifugation (100 000g, 60 min), the supernatant was applied to
a DEAE anion-exchange chromatography (eluted with 20 mM Tris-HCl (pH 8.0) containing
100 mM NaCl). The protein was further purified using Rotofor (Bio-Rad Laboratories,
Hercules, CA) pH 5-8 and loaded onto a Superose 12 gel-filtration column (Amersham
Biosciences, Piscataway, NJ), and the catalytically active fractions were collected.
Protein Concentration Determination. Protein concentration was determined according to
the method of Smith et al. (18). Briefly, a solution (180 μL) of bicinchoninic acid protein assay
reagents A and B (Pierce, Rockford, IL, a ratio of 50:1) was added to 20 μL of protein samples.
The mixture was incubated for 30 min at 37 °C before absorbance was measured at 562 nm.
On the basis of a standard curve of bovine serum albumin, absorbance was converted into
protein concentration.
Fluorescent Assays. Assays were performed by the method of Huang et al. (13). In short,
fluorescent assays were conducted with a Spectrafluor Plus (Tecan, Research Triangle Park,
NC). Activities were measured in black 96-well polystyrene flat-bottom microtiter plates
(Corning, Inc., New York, NY) at 30 °C. Substrates were prepared in ethanol (10 mM, except
for fenvalerate analogues, which also contained 10% Me2SO). Reaction mixtures contained
(total volume 201 μL): 20 μL of protein solution, 180 μL of 20 mM Tris/HCl buffer (pH 8.0),
and 1 μL of substrate solution. Previous studies demonstrated less than 1% loss of the total of
the aldehyde regardless of whether phosphate or tris buffer were used during the reaction. The
reaction was initiated by the addition of 1 μL of substrate solution (final concentration 50 μM)
followed by shaking for 5 s. This substrate final concentration (50 μM) was chosen because it
is at least 10-fold higher than the Km(s) for most stereoisomers and we considered limitation
of the substrate solubility (solubility limitation for cypermethrin and fenvalerate analogues are
around 10 and 2 μM, respectively, under pH 8.0, 20 mM tris/HCl buffer containing 0.5%
ethanol). Three replicates were conducted for each substrate. Fluorescence was monitored with
excitation at 330 nm (band-pass, [bp] 35) and emission at 465 nm (bp 35; excitation maximum)
330 nm; emission maximum) 460 nm). Assays for chiral pyrethroid substrates were conducted
with five flashes (15 cycles) to give a ∼5 min linear assay. The amount of protein in each assay
varied with the substrate and was adjusted so that no more than 5% of the substrate was
hydrolyzed over the reported time. A standard curve of the dependence of aldehyde
fluorescence response on protein concentration was generated by adding an equivalent amount
of each protein sample as used in enzymatic assays to adjust for the protein-induced aldehyde
quenching.
Kinetic Assays. Kinetic assays were performed by the method of Huang et al. (13). Fluorescent
assays for both BAC36707 and hCE1 were conducted according to the procedure described
above, except for a 5-min incubation at 30 °C before adding substrates. The concentrations of
cypermethrin analogues were 9.0, 4.5, 2.7, 1.8, 0.9, 0.45, 0.225, and 0.022 5 (μM final
concentration), respectively. Three independent replicates were conducted for each
concentration. Reported kinetic data (Km and Vmax) were calculated based on the Michaelis-
Menten equation and three replicates.
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Manual Docking Studies. Cypermethrin and fenvalerate analogues were manipulated and
docked manually using O (19) into the active site of the hCE1-homatropine structure (RCSB
accession code 1MX5) after all ligand, water, and carbohydrate atoms were removed from the
structure for simplicity. Placement was restricted so that the ester linkages were in proximity
to the active site serine 221. All molecular graphics figures were created using PyMOL (20).
Results
Biochemical Results. The results of fluorescent assays (Table 1) suggested that selective
activities of CEs toward cypermethrin analogues varied greatly among different stereoisomers
and among different CEs. Briefly, the two chiral centers in the acid moiety of the cypermethrin
analogues produced more dramatic effects on hydrolysis than the chiral center in the alcohol
moiety (cyanohydrin) for both purified CEs (hCE1, NM_133960 and BAC36707) and for a
mixture of isozymes such as porcine and rabbit liver CEs. Selective activities for trans-isomers
were generally higher than cis-isomers. For example, CEs, except for hCE1, exhibited highest
hydrolytic activity toward the (1S trans, αS) stereoisomer, with up to 2-fold lower hydrolytic
activity toward the corresponding diastereomer (1S trans, αR). However, the overall pattern
of stereoselectivity for each CE displayed little difference. For this study, we consider the
enzyme to show a preference toward one stereoisomer if it ishydrolyzed over 5 times faster
than the least favored isomer in a single series. For example, porcine liver CEs preferred five
stereoisomers (1R trans, αR;1R trans, αS; 1R cis, αS; 1S trans, αR; and 1S trans, αS) to the
other three (1R cis, αR; 1R cis, αS; and 1S cis, αS). However, purified hCE1 only favored
trans-isomers (1R trans, αR; 1R trans, αS;1S trans, αS; and 1S trans, αS). In addition, the
highest activities varied with CEs, ranging from hCE1 (55.2 (nmol/min)/mg) to BAC36707
(327 (nmol/min)/mg).
Similarly, stereoisomerism also greatly affected the specific activities of CEs toward the
fenvalerate analogues (Table 1). In general, the stereoselectivity of porcine liver CEs was poor,
but all other CEs favored the 2R form in the acid moiety, and the chiral center in the alcohol
moiety did not make a significant difference in the stereoselective activity. The highest
activities varied greatly with CEs, ranging from hCE1 (0.58 (nmol/min)/mg) to BAC36707
(54.2 (nmol/min)/mg).
Kinetic Analysis of Carboxylesterases toward Cypermethrin Analogues. To evaluate the
stereoselectivity of CEs toward pyrethroid-like fluorescent substrates, CEs (e.g., hCE1,
BAC36707) and cypermethrin analogues were chosen because these CEs could hydrolyze all
stereoisomers of cypermethrin analogues. The specificity (kcat/Km, Table 2) suggested that the
stereoselectivity of hCE1 and BAC36707 toward the most sensitive isomer and the least
sensitive one was up to 41 (1R trans, αS versus 1S cis, αR) and 150 (1S trans, αS versus 1R
cis, αS), respectively. Additionally, there was a small difference in Km for both CEs (2.6-fold
for BAC36707 and 8.3-fold for hCE1), but a dramatic difference in kcat (over 300 times) for
both hCE1 and BAC36707.
Structural Basis of the Stereoselective Hydrolysis by hCE1 toward Pyrethroid-like
Fluorescent Substrates. The overall domain structure of hCE1 and general mechanism of
biochemical assays are shown in Figure 2. hCE1 was chosen as the model for manual docking
studies because the other crystal structure of a mammalian CE (e.g., rabbit liver CE, rCE) lacks
important loops adjacent to the active site that may affect proper configuration of placed
molecules. Cypermethrin or fenvalerate analogues were considered to enter the substrate-
binding gorge from the direction opposite the catalytic site. After cleavage, the alcohol moiety
(or cyanohydrin) exits the active site gorge, and then rearranges immediately into a fluorescent
aldehyde under neutral to basic conditions. Production of the resulting fluorescent aldehyde
was subsequently measured with a fluorescence spectrophotometer. At the substrate-binding
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site, there are two loops of interest that presumably affect the binding of the substrate and hCE1
(Figure 3). These loops are referred to as Ser loop (219-225), which contains the catalytic serine
221, and the oxyanion hole (140-144) containing the Gly 142-Gly 143 pocket for stabilization
of the transition state. Both of two loops were considered to be rigid, a supposition supported
by the low crystallographic thermal displacement parameters (B-factors) observed for these
regions relative to the remainder of the structure. When the 1S trans, αR and 1R trans, αS
cypermethrin analogues were manually docked into the active site, few structural differences
were evident that explained the 2.5-fold preference in specific activity (Table 1). However,
when 1S cis, αR was modeled over 1S trans, αR, a clear difference was observed (Figure 3a).
Switching the chirality from trans to cis made the dichlorovinyl group protrude into the main
chain of the oxyanion hole effectively blocking the active site Ser 221 from accessing the
carbonyl carbon. Similar steric clashes were observed in 1R cis-isomers, but not in 1R trans-
isomers. These steric clashes likely explain the >20-fold difference in specific activity between
cis- and trans-isomers of cypermethrin analogues (Table 1). Similarly, for fenvalerate
analogues, a reversal of chirality from 2R, αS into 2S, αR caused a severe steric clash by both
isomers of fenvalerate analogues. The stereoselective hydrolysis of fenvalerate analogues by
hCE1 resulted from a differential degree in the steric clash, although it was much smaller for
2R-isomers (e.g., 2R, αS) (Figure 3b left panel) than for 2S-isomers (e.g., 2S, αR) (Figure 3b,
right panel). The fact that all fenvalerate analogues produced steric clashes also explains why
the highest activities for fenvalerate analogues (2R-isomers) were similar to those of cis-
isomers of cypermethrin analogues (Table 1), which also exhibited steric clashes.
Discussion
In insects, mammals, and humans, major metabolic enzymes that detoxify pyrethroids in the
first phase of drug metabolism are esterases and monooxygenases (21,22). Although these
enzymes distribute in multiple organs and tissues, the highest activities of these enzymes are
found to be in mammalian livers (2). Indirect and direct evidence has indicated that pyrethroids
are largely metabolized in mammalian livers (10,11,15,23-26). Thus, further metabolic studies
with hepatic carboxylesterases and other enzymes may address organ selective metabolism.
Pyrethroids and pyrethroid-like fluorescent substrates are stereoselectively hydrolyzed by
hepatic CEs. Among ester-containing pyrethroids, fenvalerate is the best studied in terms of
stereoselective hydrolysis by hepatic CEs. Experiments suggest that the hydrolysis of the four
isomers of fenvalerate in mice (in vivo) follows the same pattern of stereoselectivity (i.e., 2R-
isomers of fenvalerate are more rapidly hydrolyzed than its 2S-isomers) as that seen in in
vitro studies with the mouse extracts (26). This stereoselective pattern was further supported
by studies with purified mouse liver CE (e.g., BAC36707 (11)). Similarly, this stereoselective
pattern is also generally predictable for fenvalerate analogues.
In this study, a similar pattern of stereoselective hydrolysis of four isomers of fenvalerate
analogues was followed by purified hCE1, BAC 36707, NM_133960, and a mixture of
isozymes such as CEs from rabbit liver. However, there is a moderate deviation from this
stereoselective pattern for porcine liver CEs. The activity toward 2R, αS was the highest among
the four isomers, whereas the activity toward 2R, αR was significantly lower that those toward
2S, αR and 2S, αS. These results were in agreement with a previous study with a racemic mixture
of 2R, αR/S or 2S, αR/S, in which 2R-isomers of fenvalerate analogues were preferred to its
2S-isomers by human and murine liver microsomes but not porcine liver CEs (27). For
cypermethrin, a complete spectrum of stereoselective hydrolysis of eight stereoisomers by
hepatic CEs is not available. However, it is well-known that trans-isomers of cypermethrin
and other pyrethroids with a cyclopropane ring (e.g., permethrin, deltamethrin) are generally
more rapidly hydrolyzed by hepatic CEs than the corresponding cis-isomers (12,23,25). This
general pattern is also supported by the fact that the trans-isomers of cypermethrin analogues
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were generally preferred over the cis-isomers (Table 1). Unlike the unique pattern of
stereoselective hydrolysis of fenvalerate and its analogues by hepatic CEs, however, the
detailed stereoselectivity of cypermethrin analogues varied greatly across the spectrum of CEs.
For example, hCE1 preferred all trans-isomers of cypermethrin analogues to its cis-isomers,
but 1R cis, αS was a better substrate for NM_133960 than two isomers with the 1R trans-
configuration in the acid moiety. In addition, the chiral center(s) in the acid moiety for
cypermethrin analogues influenced hydrolytic rates more dramatically than that in the alcohol
moiety (cyanohydrin) for all examined hepatic CEs, similar to fenvalerate results.
The origin of these general patterns of stereoselective hydrolysis of pyrethroid-like fluorescent
substrates byhCE1 was examined through structural modeling and produced a proposed
mechanism (Figures 2 and 3). As a result of sharing the same acid moiety between pyrethroids
and pyrethroid fluorescent substrates, this proposed mechanism probably also fits for
hydrolysis of pyrethroids by hCE1. Steric clashes between the specific isoforms and the active
sites of hCE1 appear to explain why trans-isomers of other pyrethroids (e.g., permethrin,
deltamethrin) with a cyclopropane ring are metabolized faster in hCE1 or humans than their
corresponding cis isomer. For example, levels of trans-isomers in human serum were below
the limits of detection within 25 h after oral ingestion of an emulsifiable concentrate
formulation of permethrin, whereas cis-permethrin was still present at detectable levels 10 days
after exposure (28). A similar pattern of stereoselective hydrolysis of pyrethroids and their
fluorescent analogues by mammalian and human hepatic CEs (14) suggests that the interaction
between pyrethroid-like fluorescent substrates and the substrate-binding site of hCE1 may be
a general phenomenon for hepatic CEs and all other carboxylesterases because all
carboxylesterases share similar three-dimensional structure (1). However, stereoselectivity is
inherently difficult to characterize because it strongly relies on the three-dimensional structures
involved, and these can vary considerably due to intramolecular motions and intermolecular
interactions. For example, there was >10-fold difference in selective activities between 1R
trans- and 1S trans-isomers of cypermethrin analogues by both recombinant murine liver CEs.
Similarly, under the best configuration (1S trans) in the acid moiety of cypermethrin analogues,
the activity of the isomer (1S trans, αS) with S-cyanohydrin was higher than that (1S trans,
αR) with R-cyanohydrin. Two possible structural explanations for these observations are that
(1) the substrate-binding sites in the mouse CEs, in an undetermined way, sterically restrict
1R trans-isomers (but not 1S trans-isomers) from aligning properly for a nucleophilic attack
by the catalytic serine; or (2) the orientation of 1S trans-isomers in the substrate-binding sites
facilitates the hydrogen-bond formation between the catalytic histidine and the oxygen (C-O-
C) of the ester bond, but the orientation of 1R trans-isomers does not. The latter has been used
as an explanation for why lipases from Candida rugosa and C. antarctica exhibit a strong
preference for the R-ester with a secondary alcohol to its S-ester (29,30). A missing hydrogen
bond between the catalytic histidine and the oxygen of S-esters has been suggested to account
for these particular observations of stereoselectivity. Additional structural analyses will be
required to establish what the detailed nature of such stereoselectivities is.
The structure-guided explanation of stereoselective hydrolysis of pyrethroid-like substrates by
CEs presented in this paper provides information that may be useful in the development of
improved inhibitors for pyrethroidhydrolyzing esterases and the development of novel
insecticides. The aim of designing efficacious inhibitors for pyrethroid-hydrolyzing esterases
is to control the propagation of agricultural pests and disease vectors (e.g., mosquitoes), in
which an enhanced esterase-mediated metabolism is a major metabolic mechanism of
pyrethroid resistance (31,32), while having little effect on mammals. Thus, inhibition of
esterase-mediated hydrolysis in resistant pests will potentially restore the insecticidal efficacy
of pyrethroids on previously resistant insects. Although carbamates and organophosphates are
excellent inhibitors of esterases, and they have been used as synergists of ester-containing
pyrethroids in some countries, they are not selective, and some are toxic to mammals and
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nontarget organisms. Inhibitors with structures similar to pyrethroids may be more selective
than general carbamates and organophosphates, and they may offer less risk of toxicity. On
the basis of the specific activity (Table 1) and structural examination, compounds with a three-
dimensional configuration matching (1S trans, αS) appear to the best structure for pyrethroid-
selective inhibitors. In contrast, efforts to develop new ester-containing pyrethroids with a
cyclopropane ring should avoid 1S trans-configuration, and those directed further
developments of ester-containing compounds with a noncyclopropane ring should avoid a
2R-configuration since ester-containing compounds with 1S trans- or 2R-configuration are
easily hydrolyzed, and thus, detoxified by mammalian carboxylesterases.
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Structural labels for different stereoisomers of cypermethrin and fenvalerate analogues.
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Overall domain structure of human carboxylesterase 1 (hCE1) and general mechanism of
activity assays. Cypermethrin and fenvalerate structures are shown in stick models with
transparent CPK surface. Arrows represent mechanistic steps resulting in fluorescent aldehyde
which is measured spectrophotometrically. hCE1 domains are colored red (catalytic domain),
blue (αβ domain), and gold (regulatory domain).
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Proposed binding of cypermethrin and fenvalerate analogues just prior to catalysis: comparison
of stereochemistry and activity. Active site loops with terminal amino acids labeled. Loop
140-144 represents the oxyanion hole, while loop 219-225 represents the active site serine
loop. Ser 221 is shown in stick model, labeled in gray. Ligands are shown in stick models with
CPK transparent surfaces. (a) Cypermethrin analogues 1S cis αR shown in blue with 1S
trans αR shown in green. (b) Fenvalerate analogues 2R, αS shown in yellow with 2S, αR shown
in blue.
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Table 1
.Specific Activity of Mammalian and Human Liver Carboxylesterases toward Pyrethroid-like Fluorescent
Substratesa
substrates porcineb rabbitb human hCE1c mouse NM_133960d mouse BAC36707d
Cypermethrin Analogues
1R cis, αR 2.35(0.17) 5.67(0.49) 0.60(0.02) 3.94(0.37) 19.74(2.18)
1S cis, αR 2.45(0.22) 5.71(0.83) 0.36(0.13) 7.44(0.66) 8.44(0.37)
1R trans, αR 26.8(1.8)e 12.2(1.4) 16.0(1.60)e 7.63 (0.27) 26.2(2.8)e
1S trans, αR 51.0(2.6)e 37.5(2.6)e 21.3(2.2)e 85.1(3.2)e 281(24)e
1R cis, αS 33.4(4.5)e 7.41(0.04) 0.64(0.06) 20.3(0.1)e 2.28(0.31)
1S cis, αS 6.62(0.46) 3.73(0.37) 0.66(0.05) 8.69(0.85) 6.69(1.06)
1R trans, αS 42.4(3.8)e 55.6(7.5)e 55.2(3.1)e 7.34(0.76) 14.6(1.2)e
1S trans, αS 61.2(1.8)e 83.4(11.3)e 14.7(1.3)e 155(2)e 327(25)e
Fenvalerate Analogues
2R,αR 1.62(0.07) 17.1(1.0)e 0.38(0.01)e 10.3(0.4)e 40.3(2.6)e
2R, αS 8.34(0.35) 15.0(0.4)e 0.58(0.10)e 15.2(0.3)e 54.2(3.4)e
2S,αR 4.31 (0.32) 0.25(0.04) NDf 0.63(0.05) NDf
2S, αS 2.66(0.20) 4.61(0.04) 0.04(0.03) 0.79(0.11) NDf
a
Values stand for mean activities ((nmol/min)/mg protein, SD in parentheses) based on triplicate assays.
b
Porcine and rabbit liver carboxylesterases are commercial from Sigma-Aldrich; they were mixtures of multiple isozymes.
c
Human (hCE1) carboxy-lesterase was expressed in insect cells with a recombinant bacu-lovirus expression system, then recombinant hCE1 was
sequentially purified by anion-exchange chromatography, preparative electrophoresis, and gel-filtration chromatography.
d
Mouse: two recombinant mouse liver carboxylesterase (NCBI accession nos. NM_133960 and BAC36707) were recently purified (12), and data were
presented in ref 13.
e
Preference was considered if one stereoisomer is hydrolyzed by one carboxylesterase over 5 times faster than the least favored isomer in a single series.
f
ND = not detectable under the same protein as other stereoisomers.
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Table 2
.Kinetic Constants for Carboxylesterases toward Cypermethrin Analogues
CEs substrate Km (μM) kcat( × 10-4s-1) kcat/Km(M-1s-1)
hCE1 1S cis, αR 2.3 ± 0.5 1.8 ± 0.1 78 ± 4
1R trans, αS 19.0 ± 1.2 600 ± 30 3200 ± 200
BAC36707a 1R cis, αS 1.68 ± 0.06 20 ± 2 1200 ± 200
1S trans, αS 4.36 ± 0.34 7700 ± 1300 180000 ± 30000
a
Data were presented in ref 13.
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